WeRide Inc. — Board/Management Information 2005

Mar 21, 2005

The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [61 x 62] intentionally omitted <==

FAR EAST PHARMACEUTICAL TECHNOLOGY COMPANY LIMITED

(Incorporated in the Cayman Islands with limited liability) (Provisional Liquidators Appointed) (Stock Code: 399)

CLARIFICATION ANNOUNCEMENT

We refer to the Chinese version of the announcement dated 17 March 2005 relating to the Changes in Directorships, Secretary and Principal Place of Business of Far East Pharmaceutical Technology Company Limited (Provisional Liquidators Appointed) (“the Company”) where, due to a typing error, the date of the change of principal place of business of the Company in Hong Kong was incorrectly typed as 8 October 2004. The correct date of the change of principal place of business of the Company in Hong Kong should be 22 September 2004.

Please note that this announcement is only released on the AMS/3 Trading Terminal and the website of The Stock Exchange of Hong Kong Limited and has not been published in the newspapers as required by the Listing Rules due to the liquidity problem of the Company.

As at the date of this announcement, the Board of Directors of the Company consists of two independent non-executive directors, namely Mr. Chiu Koon Shou, Victor, and Mr. Lo Wah Wai, Lowell.

For and on behalf of Far East Pharmaceutical Technology Company Limited (Provisional Liquidators Appointed) Darach E. Haughey Joint and Several Provisional Liquidator

Hong Kong, 18 March 2005